EquiVita Genetics

EquiVita Genetics is a biotechnology startup that specializes in applying advanced techniques from human medicine to veterinary science, with a specific focus on equine reproduction. The company aims to make horse breeding processes more efficient and effective. It leverages its expertise in reproductive technologies to address challenges in the equine industry.

Founded in January 2024 by Sofie Piepers and Maarten D'Hondt, EquiVita Genetics is located in Merelbeke, Oost-Vlaanderen, Belgium. The founders bring a blend of scientific knowledge and entrepreneurial spirit to the venture. Sofie Piepers holds a PhD and is also the founder of Fetal Health, which focuses on non-invasive prenatal testing, indicating a strong background in advanced medical diagnostics. Maarten D'Hondt has a background in bioscience engineering and has held positions in sales and business development, including a role as a Key Account Manager at Thermo Fisher Scientific.

The company operates out of Ghent University, suggesting a strong connection to academic research and development. Its business model centers on providing specialized services and technologies to veterinarians, stud farms, and horse owners to improve the outcomes of equine breeding.

Keywords: equine reproduction, veterinary technology, biotechnology, horse breeding, animal genetics, assisted reproductive technology, veterinary medicine, embryology, animal health, livestock technology